Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Non-Current Deferred Tax Liability (2019 - 2021)

Historic Non-Current Deferred Tax Liability for Legend Biotech (LEGN) over the last 3 years, with Q4 2021 value amounting to $22.8 million.

  • Legend Biotech's Non-Current Deferred Tax Liability fell 3504.65% to $22.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was $22.8 million, marking a year-over-year decrease of 3504.65%. This contributed to the annual value of $22.8 million for FY2021, which is 3504.65% down from last year.
  • As of Q4 2021, Legend Biotech's Non-Current Deferred Tax Liability stood at $22.8 million, which was down 3504.65% from $35.0 million recorded in Q4 2020.
  • In the past 5 years, Legend Biotech's Non-Current Deferred Tax Liability registered a high of $47.7 million during Q4 2019, and its lowest value of $22.8 million during Q4 2021.
  • For the 3-year period, Legend Biotech's Non-Current Deferred Tax Liability averaged around $35.2 million, with its median value being $35.0 million (2020).
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first tumbled by 2654.28% in 2020, then tumbled by 3504.65% in 2021.
  • Quarter analysis of 3 years shows Legend Biotech's Non-Current Deferred Tax Liability stood at $47.7 million in 2019, then dropped by 26.54% to $35.0 million in 2020, then crashed by 35.05% to $22.8 million in 2021.
  • Its last three reported values are $22.8 million in Q4 2021, $35.0 million for Q4 2020, and $47.7 million during Q4 2019.